Valuing rare disease treatments in healthcare: Real experience, real impact
Richard Chapman,Chief Science Officer, Innovation and Value Initiative
Rare Disease Advocacy World
13:05
International Rare Disease Research Consortium (IRDiRC): A multi-stakeholder approach to understanding the needs in developing Rare Disease diagnostics and therapies